Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05675254
Other study ID # No. 2022-355
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2022
Est. completion date December 24, 2022

Study information

Verified date December 2022
Source Children's Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The hematologic consequences of novel Anti-seizure medications (ASMs) are rarely reported. Whether coagulation dysfunctions increase the risk of peri-operative bleeding remains controversial. The research is performed to investigated the incidence and risk factors of preoperative coagulation dysfunction in children undergoing surgery for epilepsy and their impact on surgery.


Description:

Epilepsy is a common disease of the nervous system with severe consequences. Epidemiological surveys have shown that the prevalence of epilepsy in China is approximately 0.4-0.7%, comprising 7-10 million patients with epilepsy, most of whom are children. Although most symptoms of epilepsy can be controlled with the use of anti-seizure medications (ASMs), there are still a few patients who cannot achieve satisfactory seizure control with such medications or cannot tolerate their side effects, thus requiring surgical treatment. Surgical treatment of epilepsy has been recognized as a valuable treatment option for carefully selected patients to achieve better seizure control and quality of life. Compared to adults, children with epilepsy with indications for surgery usually have a better prognosis after surgical treatment. Many children undergoing surgery for epilepsy have a long history of using ASMs. Moreover, ASM therapy usually consists of multiple varieties of drugs, thereby bringing significant attention to the side effects of ASMs, especially those that may be relevant in the perioperative surgical setting. ASMs have been associated with multiple adverse effects on platelets and the coagulation system. Valproic acid (VPA), one of the most commonly used traditional ASM, has been reported to cause multiple hematologic abnormalities, including thrombocytopenia, platelet aggregation dysfunction, fibrinogen (FBG) depletion, bone marrow suppression, decreased factor XIII, and acquired von Willebrand disease. However, the wide use of novel ASMs in recent decades has led to decreased reports of adverse events. The hematologic consequences of these novel ASMs or combined therapies are rarely reported. Few studies have suggested that levetiracetam (LEV) does not cause clinically significant or relevant hematological disorders. Such reported side effects may be more significant in pediatric patients with epilepsy due to individual differences in age, weight, and pharmacokinetic action of the body on the drugs. The incidence of coagulopathies has been reported to be higher in children than in adults, especially hypofibrinogenemia. Nevertheless, whether these coagulation dysfunctions increase the risk of peri-operative bleeding remains controversial. Most investigators suggest that ASMs, including VPA, are not associated with surgery-related blood loss or transfusion requirements. However, a few studies have suggested that considering the extra risk of peri-operative bleeding, VPA should be discontinued before surgery. This retrospective analysis of 390 children with epilepsy systematically investigated the incidence and risk factors of preoperative coagulation dysfunction in children undergoing surgery for epilepsy and their impact on surgery, with the objective to provide detailed and valuable clinical information.


Recruitment information / eligibility

Status Completed
Enrollment 494
Est. completion date December 24, 2022
Est. primary completion date December 24, 2022
Accepts healthy volunteers No
Gender All
Age group 1 Month to 18 Years
Eligibility Inclusion Criteria: - Age<18 years - A discharge diagnosis of "epilepsy" according to the International Classification of Diseases (ICD-10) - Received surgical treatment for epilepsy during the hospitalization - Hospitalized between January 2015 and December 2021 at the Neurosurgery Department of Children's Hospital of Fudan University - Non-epileptic children who underwent non-epilepsy neurological surgery by the same surgeon and were admitted at the same period for control Exclusion Criteria: - The clinical information or laboratory examinations were incomplete - Had concomitant diseases affecting coagulation or liver function - Patients or parents refused to be enrolled

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Children's Hospital of Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Fudan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Factors related to coagulation function The following clinical data were collected: sex, age, weight, epilepsy course, and anti-seizure therapy. The initial laboratory data after admission included platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), FBG, alanine aminotransferase (ALT), and aspartate aminotransferase (AST).
We also collected data on non-epileptic children who underwent non-epilepsy neurological surgery and were admitted at the same period from the Hospital Information System (HIS) as a control cohort.
Multivariate logistic regression analysis was performed to identify independent determinants of coagulation dysfunction. Possible relevant variables were filtered out using univariate logistic regression and further included as covariates for the multivariate logistic regression.
From hospitalization to surgery, an average of 3 days
Secondary Proportion of coagulation dysfunction between groups Proportion of cases with or without coagulation dysfunction in epileptic children with ASMs, epileptic children without ASMs, and non-epileptic children. From hospitalization to surgery, an average of 3 days
Secondary Variables affecting coagulation function Univariate analysis and logistic regression identified the risk factors for coagulopathy in paediatric patients undergoing epilepsy surgery. From hospitalization to surgery, an average of 3 days
Secondary Affected laboratory index Laboratory index affected by the independent determinants of coagulation dysfunction (PT, APTT, FBG or PLT). From hospitalization to surgery, an average of 3 days
Secondary Incidence of transfusion Whether the independent determinants of coagulation dysfunction increase the incidence of surgical-related transfusion. From surgery to discharge, an average of 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT06202976 - Mapping Epileptic Networks Using Multimodal Imaging
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Recruiting NCT05885646 - Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Completed NCT06400966 - The Effect of Jigsaw Technique on Childhood Epileptic Seizure Management Knowledge and Attitudes of Nursing Students N/A
Not yet recruiting NCT06388577 - The Effect of the Training Programme Based on the Health Promotion Model Given to Parents N/A
Not yet recruiting NCT06402526 - Evaluating the Efficacy of a Mobile Epilepsy Education Application N/A
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Recruiting NCT06444126 - The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
Withdrawn NCT04308252 - Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy
Recruiting NCT06300814 - The Effect of Exercise and Music on Sleep, Quality of Life and Emotional State in Children With Epilepsy N/A
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05439876 - Getting SMART for Pediatric Epilepsy Phase 2/Phase 3
Not yet recruiting NCT06455384 - The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services N/A
Recruiting NCT05323682 - Physical Excercise Program in Children With Drug-resistant Epilepsy N/A
Recruiting NCT04584385 - Advanced EEG Technology in Childhood Epilepsy
Not yet recruiting NCT04219930 - Nucleotide Protein -3 in Epileptic Children
Completed NCT04020484 - Making Mindfulness Matter© in Children With Epilepsy N/A
Recruiting NCT06093490 - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Recruiting NCT05740423 - Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy